236 related articles for article (PubMed ID: 22775587)
1. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
Master AM; Livingston M; Oleinick NL; Sen Gupta A
Mol Pharm; 2012 Aug; 9(8):2331-8. PubMed ID: 22775587
[TBL] [Abstract][Full Text] [Related]
2. A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.
Master A; Malamas A; Solanki R; Clausen DM; Eiseman JL; Sen Gupta A
Mol Pharm; 2013 May; 10(5):1988-97. PubMed ID: 23531079
[TBL] [Abstract][Full Text] [Related]
3. EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies.
Master AM; Qi Y; Oleinick NL; Gupta AS
Nanomedicine; 2012 Jul; 8(5):655-64. PubMed ID: 22024195
[TBL] [Abstract][Full Text] [Related]
4. Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies.
Master AM; Rodriguez ME; Kenney ME; Oleinick NL; Gupta AS
J Pharm Sci; 2010 May; 99(5):2386-98. PubMed ID: 19967780
[TBL] [Abstract][Full Text] [Related]
5. Targeted Photodynamic Therapy (PDT) of Lung Cancer with Biotinylated Silicon (IV) Phthalocyanine.
Dong W; Li K; Wang S; Qiu L; Liu Q; Xie M; Lin J
Curr Pharm Biotechnol; 2021; 22(3):414-422. PubMed ID: 32386488
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
Whitacre CM; Feyes DK; Satoh T; Grossmann J; Mulvihill JW; Mukhtar H; Oleinick NL
Clin Cancer Res; 2000 May; 6(5):2021-7. PubMed ID: 10815928
[TBL] [Abstract][Full Text] [Related]
7. π-π Stacking induced enhanced molecular solubilization, singlet oxygen production, and retention of a photosensitizer loaded in thermosensitive polymeric micelles.
Shi Y; Elkhabaz A; Yengej FA; van den Dikkenberg J; Hennink WE; van Nostrum CF
Adv Healthc Mater; 2014 Dec; 3(12):2023-31. PubMed ID: 25388924
[TBL] [Abstract][Full Text] [Related]
8. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
[No Abstract] [Full Text] [Related]
9. Immunosuppressive effects of silicon phthalocyanine photodynamic therapy.
Reddan JC; Anderson CY; Xu H; Hrabovsky S; Freye K; Fairchild R; Tubesing KA; Elmets CA
Photochem Photobiol; 1999 Jul; 70(1):72-7. PubMed ID: 10420845
[TBL] [Abstract][Full Text] [Related]
10. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
van Driel PBAA; Boonstra MC; Slooter MD; Heukers R; Stammes MA; Snoeks TJA; de Bruijn HS; van Diest PJ; Vahrmeijer AL; van Bergen En Henegouwen PMP; van de Velde CJH; Löwik CWGM; Robinson DJ; Oliveira S
J Control Release; 2016 May; 229():93-105. PubMed ID: 26988602
[TBL] [Abstract][Full Text] [Related]
11. Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.
Baron ED; Malbasa CL; Santo-Domingo D; Fu P; Miller JD; Hanneman KK; Hsia AH; Oleinick NL; Colussi VC; Cooper KD
Lasers Surg Med; 2010 Dec; 42(10):728-35. PubMed ID: 21246576
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells.
Azizuddin K; Kalka K; Chiu SM; Ahmad N; Mukhtar H; Separovic D
Int J Oncol; 2001 Feb; 18(2):411-5. PubMed ID: 11172611
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy.
Jiang Z; Shao J; Yang T; Wang J; Jia L
J Pharm Biomed Anal; 2014 Jan; 87():98-104. PubMed ID: 23746989
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic necroptosis in the anti-tumor photodynamic action of BAM-SiPc, a silicon(IV) phthalocyanine-based photosensitizer.
Zhang Y; Cheung YK; Ng DKP; Fong WP
Cancer Immunol Immunother; 2021 Feb; 70(2):485-495. PubMed ID: 32839829
[TBL] [Abstract][Full Text] [Related]
15. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
16. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells.
De Groof TWM; Mashayekhi V; Fan TS; Bergkamp ND; Sastre Toraño J; van Senten JR; Heukers R; Smit MJ; Oliveira S
Mol Pharm; 2019 Jul; 16(7):3145-3156. PubMed ID: 31244224
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles.
Yan S; Huang Q; Chen J; Song X; Chen Z; Huang M; Xu P; Zhang J
Int J Nanomedicine; 2019; 14():6799-6812. PubMed ID: 31692522
[TBL] [Abstract][Full Text] [Related]
18. Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer.
Wang D; Fei B; Halig LV; Qin X; Hu Z; Xu H; Wang YA; Chen Z; Kim S; Shin DM; Chen ZG
ACS Nano; 2014 Jul; 8(7):6620-32. PubMed ID: 24923902
[TBL] [Abstract][Full Text] [Related]
19. PEGylated Dendrimers as Drug Delivery Vehicles for the Photosensitizer Silicon Phthalocyanine Pc 4 for Candidal Infections.
Hutnick MA; Ahsanuddin S; Guan L; Lam M; Baron ED; Pokorski JK
Biomacromolecules; 2017 Feb; 18(2):379-385. PubMed ID: 28117573
[TBL] [Abstract][Full Text] [Related]
20. Functional titanium dioxide nanoparticle conjugated with phthalocyanine and folic acid as a promising photosensitizer for targeted photodynamic therapy in vitro and in vivo.
Liang X; Xie Y; Wu J; Wang J; Petković M; Stepić M; Zhao J; Ma J; Mi L
J Photochem Photobiol B; 2021 Feb; 215():112122. PubMed ID: 33433386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
